Renal Cancer - Results from #3360

Prognostic value and immune infiltration of novel signatures in clear cell renal cell carcinoma microenvironment. September 9, 2019

A Phase I Study of Alpha-1,3-Galactosyltransferase-Expressing Allogeneic Renal Cell Carcinoma Immunotherapy in Patients with Refractory Metastatic Renal Cell Carcinoma. September 9, 2019

Exploring the mechanism of clear cell renal cell carcinoma metastasis and key genes based on multi-tool joint analysis. September 9, 2019

FABP5 is correlated with poor prognosis and promotes tumour cell growth and metastasis in clear cell renal cell carcinoma. September 9, 2019

Association between ACYP2 polymorphisms and the risk of renal cell cancer. September 7, 2019

Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial. September 7, 2019

Preliminary results indicate increased expression of miR-184 in patients with renal carcinoma. September 7, 2019

Optimal dose of sunitinib for long-term treatment in Japanese patients with renal cell carcinoma. September 6, 2019

Association among the R.E.N.A.L. nephrometry score and clinical outcomes in patients with small renal masses treated with percutaneous contrast enhanced ultrasound radiofrequency ablation. September 6, 2019

The Prognostic Significance of Protein Expression of CASZ1 in Clear Cell Renal Cell Carcinoma. September 6, 2019

Surgical intervention in renal cell carcinoma patients with lung and bronchus metastasis is associated with longer survival time: a population-based analysis. September 4, 2019

Importance of Multiparametric Evaluation of Immune-Related T-Cell Markers in Renal-Cell Carcinoma. September 4, 2019

Immunohistochemical expression of renin is a prognostic factor for recurrence in nonmetastatic renal cell carcinoma. September 4, 2019

Conditional Survival in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab. September 2, 2019

Unmarried Status is A Barrier for Access to Treatment in Patients with Metastatic Renal Cell Carcinoma September 2, 2019

Role of PDL1 as a prognostic marker in renal cell carcinoma: a prospective observational study in eastern India. August 28, 2019

Procollagen-lysine, 2-oxoglutarate 5-dioxygenases 1, 2, and 3 are potential prognostic indicators in patients with clear cell renal cell carcinoma. August 28, 2019

Comparing oncologic outcomes in patients undergoing surgery for oncocytic neoplasms, conventional oncocytoma, and chromophobe renal cell carcinoma. August 28, 2019

The Changing Therapeutic Landscape of Metastatic Renal Cancer. August 28, 2019

MicroRNA-15a tissue expression is a prognostic marker for survival in patients with clear cell renal cell carcinoma. August 28, 2019

Page 169 of 457